AV Remdesivir

Aus coViki
Wechseln zu: Navigation, Suche
  • one hospital on...
  • GET 2020. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING Extract
  • GET ä. Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites Extract
  • GET 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Extract
  • GET 2020. Rapid review for the anti-coronavirus effect of remdesivir Extract
  • GET ä. Arguments in favour of remdesivir for treating SARS-CoV-2 infections Extract
  • GET ä. Remdesivir bei Patienten mit schwerer COVID-19 Extract
  • GET ä. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease Extract
  • GET ä. Compassionate Use of Remdesivir for Patients with Severe Covid-19 Extract
  • GET 2020. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency Extract
  • GET 2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus Extract
  • GET 2020. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses Extract
  • GET 2020. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection Extract
  • GET 2020. Remdesivir, la esperanza antiviral frente al SARS-CoV-2 Extract
  • GET ä. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir Extract
  • GET ä. Remdesivir as a possible therapeutic option for the COVID-19 Extract
  • GET ä. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence Extract
  • GET 2020. Remdesivir in covid-19 Extract
  • GET 2020. Covid-19: Remdesivir is helpful but not a wonder drug, say researchers Extract
  • GET 2020. Hopes rise for coronavirus drug remdesivir Extract
  • GET ä. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 Extract
  • GET 2020. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient Extract
  • GET 2006. Remdesivir Extract
  • GET 2020. Synergistic effect of vitamin D and remdesivir can fight COVID-19. Extract
  • GET 2020. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials. Extract
  • GET 2020. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Extract
  • GET 2020. Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. Extract
  • GET 2020. Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. Extract
  • GET 2020. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Extract
  • GET 2020. Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. Extract
  • GET 2020. Early experience with remdesivir in SARS-CoV-2 pneumonia. Extract
  • GET 2020. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase. Extract
  • GET 2020. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment. Extract
  • GET 2020. [Remdesivir til behandling af COVID-19-pneumoni]. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Extract
  • GET 2020. Remdesivir bei Patienten mit COVID-19. Extract
  • GET 2020. Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID-19, in Healthy Subjects. Extract
GET 2020. Uncertainty about the Efficacy of Remdesivir on COVID-19. Extract
  • GET 2020. Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease - in silico approach. Extract
  • GET 2020. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Extract
  • GET 2020. Compassionate Use of Remdesivir in Covid-19. Reply. Extract
  • GET 2020. Compassionate Use of Remdesivir in Covid-19. Extract
  • GET 2020. Compassionate Use of Remdesivir in Covid-19. Extract
  • GET 2020. Compassionate Use of Remdesivir in Covid-19. Extract
  • GET 2020. Compassionate Use of Remdesivir in Covid-19. Extract
  • GET 2020. Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir. Extract
  • GET 2020. Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences. Extract
  • GET 2020. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. Extract
  • GET 2020. Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19. Extract
  • GET 2020. Remdesivir and Tocilizumab: Mix or Match. Extract
  • GET 2020. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Extract
  • GET 2020. Remdesivir for COVID-19: challenges of underpowered studies Extract
  • GET 2020. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient. Extract
GET 2020. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Extract
GET 2020. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Extract
  • GET 2020. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. Extract
  • GET 2020. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Extract
  • GET 2020. Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition. Extract
  • GET 2020. Remdesivir et Covid-19: resultats negatifs mais methode de recherche (enfin) appropriee ! Extract
  • GET 2020. Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? Extract
  • GET 2020. Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease. Extract
  • GET 2020. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application. Extract
  • GET 2020. Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors. Extract
Meine Werkzeuge